BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7952788)

  • 1. Prevention and management of steroid-induced osteoporosis.
    Averns HL; Chellingsworth M
    Br J Hosp Med; 1994 Jul 13-Aug 16; 52(2-3):86-9. PubMed ID: 7952788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucocorticoid-induced osteoporosis. Occurrence, prophylaxis and treatment].
    Vestergaard P; Laursen LC; Schwarz P; Brixen K
    Ugeskr Laeger; 2005 Feb; 167(8):898-900. PubMed ID: 15789844
    [No Abstract]   [Full Text] [Related]  

  • 4. [The prevention and therapy of steroid-induced osteoporosis].
    Kruse HP
    Dtsch Med Wochenschr; 1999 Dec; 124(50):1538. PubMed ID: 10633782
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroid-induced osteoporosis in patients with uveitis.
    Jones NP; Anderton LC; Cheong FM; Whallett A; Stanford MR; Murray PI; Lesnik-Oberstein S; Pavesio C
    Eye (Lond); 2002 Sep; 16(5):587-93. PubMed ID: 12194074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-induced osteoporosis: prevention and treatment.
    Werth VP
    Rev Rhum Engl Ed; 1997 Jun; 64(6 Suppl):84S-88S. PubMed ID: 9273946
    [No Abstract]   [Full Text] [Related]  

  • 7. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
    Cauza E; Etemad M; Winkler F; Hanusch-Enserer U; Partsch G; Noske H; Dunky A
    J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of corticosteroid induced osteoporosis in ovariectomized sheep. A bone histomorphometric study.
    Klopfenstein Bregger MD; Schawalder P; Rahn B; Eckhardt C; Schneider E; Lill C
    Vet Comp Orthop Traumatol; 2007; 20(1):18-23. PubMed ID: 17364091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled triamcinolone and chronic obstructive pulmonary disease.
    De Maria A; Canonica GW
    N Engl J Med; 2001 May; 344(20):1553-4; author reply 1554-6. PubMed ID: 11368045
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura].
    Hasegawa M; Nisikawa M; Nomura S; Takubo T; Suehiro A; Saigo K; Hayashi K; Tamaki S; Mizutani M; Uemura Y; Kurata Y;
    Rinsho Ketsueki; 2005 Feb; 46(2):121-6. PubMed ID: 16447705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postmenopausal osteoporosis.
    Murphy FT; Kivitz AJ; Sands EE
    J Am Osteopath Assoc; 2003 Oct; 103(10 Suppl 6):S6-11. PubMed ID: 14620079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathophysiology of postmenopausal osteoporosis].
    Korsić M
    Reumatizam; 2006; 53(2):32-5. PubMed ID: 17580551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
    Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
    Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Secondary osteoporosis. Pathogenesis of glucocorticoid-induced osteoporosis].
    Takayanagi R
    Clin Calcium; 2007 Feb; 17(2):270-4. PubMed ID: 17272886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposals for prevention and management of steroid-induced osteoporosis in children and adolescents.
    Brown JJ; Zacharin MR
    J Paediatr Child Health; 2005 Nov; 41(11):553-7. PubMed ID: 16398835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic glucocorticoid therapy and osteoporosis--an under-recognised problem in South Africa.
    Pettifor JM
    S Afr Med J; 2000 Nov; 90(11):1111-2. PubMed ID: 11196029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.